Cargando…
Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measure...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920667/ https://www.ncbi.nlm.nih.gov/pubmed/8636012 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x |
_version_ | 1783317870241906688 |
---|---|
author | Hattori, Yasushi Tashiro, Hiromi Kawamoto, Toshihiro Kodama, Yasushi |
author_facet | Hattori, Yasushi Tashiro, Hiromi Kawamoto, Toshihiro Kodama, Yasushi |
author_sort | Hattori, Yasushi |
collection | PubMed |
description | The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test‐positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow‐up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test. When the results of one year's follow‐up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X‐ray screening, if optimum criteria of a positive test are selected. |
format | Online Article Text |
id | pubmed-5920667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59206672018-05-11 Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens Hattori, Yasushi Tashiro, Hiromi Kawamoto, Toshihiro Kodama, Yasushi Jpn J Cancer Res Article The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test‐positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow‐up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test. When the results of one year's follow‐up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X‐ray screening, if optimum criteria of a positive test are selected. Blackwell Publishing Ltd 1995-12 /pmc/articles/PMC5920667/ /pubmed/8636012 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x Text en |
spellingShingle | Article Hattori, Yasushi Tashiro, Hiromi Kawamoto, Toshihiro Kodama, Yasushi Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title | Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title_full | Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title_fullStr | Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title_full_unstemmed | Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title_short | Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens |
title_sort | sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920667/ https://www.ncbi.nlm.nih.gov/pubmed/8636012 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x |
work_keys_str_mv | AT hattoriyasushi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens AT tashirohiromi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens AT kawamototoshihiro sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens AT kodamayasushi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens |